12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Atreca (BCEL) saw a 63.4% increase, while Cara Therapeutics (CARA) rose by 19.19%. Genprex (GNPX) and Conduit Pharmaceuticals (CDT) also saw gains of 18.03% and 15.12%, respectively. AIM ImmunoTech (AIM) and Better Therapeutics (BTTX) rose by 13.56% and 11.2%. Conversely, 180 Life Sciences (ATNF) dropped by 19.2%, Ekso Bionics Holdings (EKSO) by 15.55%, and cbdMD (YCBD) by 8.28%. Quoin Pharmaceuticals (QNRX), Innovative Eyewear (LUCY), and PaxMedica (PXMD) also saw declines.
January 11, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
180 Life Sciences stock fell 19.2% to $0.24, with a market cap of $2.4 million.
The significant drop in 180 Life Sciences' stock price during pre-market trading could indicate negative sentiment and a potential short-term downtrend.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Ekso Bionics Holdings shares declined by 15.55% to $1.82, with a market cap of $25.9 million.
Ekso Bionics Holdings' pre-market decline may reflect investor concerns, potentially leading to a short-term negative price movement.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Innovative Eyewear stock declined by 7.81% to $0.42, with a market cap of $5.4 million.
The pre-market decrease for Innovative Eyewear could suggest a bearish outlook for the stock in the short term, influenced by market sentiment.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
PaxMedica shares fell 6.91% to $0.65, with a market value of their outstanding shares at $2.9 million.
PaxMedica's pre-market decline may indicate a short-term negative impact on the stock price, as investor sentiment appears to be leaning negative.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Quoin Pharmaceuticals stock fell 7.99% to $4.38, with a market cap of $4.3 million.
Quoin Pharmaceuticals' stock decline in pre-market may lead to a negative short-term trend as the market reacts to the price change.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
cbdMD shares decreased by 8.28% to $0.94, with a market cap of $2.7 million.
The pre-market drop in cbdMD's stock price could signal a bearish sentiment among investors, possibly affecting the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
AIM ImmunoTech's stock increased by 13.56% to $0.52, with a market cap of $25.3 million.
AIM ImmunoTech's stock rise in pre-market may lead to short-term positive momentum as investors react to the price movement.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Atreca's stock soared by 63.4% in pre-market trading, with a market cap of $6.9 million.
The substantial pre-market gain for Atreca suggests a strong positive sentiment that could lead to increased investor interest and potentially higher trading volumes in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Better Therapeutics' shares rose 11.2% to $0.26, with a market cap of $12.9 million.
The pre-market increase for Better Therapeutics may suggest a positive short-term outlook for the stock as it garners investor interest.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Cara Therapeutics' stock increased by 19.19% to $0.74, with a market cap of $40.1 million.
Cara Therapeutics' significant pre-market rise indicates positive investor sentiment, which may lead to a short-term uptrend in the stock price.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Conduit Pharmaceuticals' stock increased by 15.12% to $4.72, with a market cap of $348.4 million.
The pre-market gain for Conduit Pharmaceuticals could indicate a bullish trend for the stock in the short term, driven by positive market sentiment.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Genprex stock rose 18.03% to $0.26, with the company's market cap at $15.4 million.
The pre-market increase for Genprex may attract investor attention and could result in a short-term positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100